Join Dr. Jackson and Dr. Kane as they discuss symptoms of schizophrenia and its impact on treatment outcomes and quality of life. The goal of this session is to help mental healthcare professionals stay up-to-date on newer antipsychotics and translate available clinical data to a patient-centric selection of antipsychotic therapies to improve adherence and treatment outcomes.
Psychopharmacology Credit: 1.25
This activity is supported by an educational grant from Allergan.